Raynaud's disease is uncommon in children. The patient described here developed Raynaud's disease subsequent to rubella when she was 7 years old. Treatment with griseofulvin brought about a rapid disappearance of the symptoms and signs.
Case History
The patient, a 7-year-old girl, with no previous history of circulatory disorder, developed rubella, and a week later a discoloration of her fingers was noted. The index finger of the right hand became purple and cold and then the index finger of her left hand became similarly affected. Other fingers were soon involved (see Fig.) and by the third week some discoloration of the toes was noticed. There was no family history of any similar disorder.
On examination at that time she was a healthy-looking girl of average build. The (Wade, 1965) ). There was a good hyperaemic response to local warming of the digits.
After 5 weeks of increasing circulatory disorder, oral treatment was started with fine particle griseofulvin, 125 mg. b.d. A subjective improvement was noticed after 3 days. After 2 weeks of treatment the infection around the finger-nails had disappeared and they were Received November 28, 1967. no longer blue. Digital skin temperatures showed some improvement (see Table) .
No abnormality was noticed in the child's fingers by the parents and she had no complaints. The weather was hot during this period and the child swam in an open unheated swimming pool without precipitating any digital circulatory changes.
Because the signs of Raynaud's disease are episodic it was decided to stop treatment at the end of 4 weeks, but within 5 days digital coolness and cyanosis had reappeared in the left hand. Treatment with griseofulvin was restarted and again within 3 days the hands became warm and pink. This treatment was continued into the winter months without any circulatory problems recurring.
Discussion
Ischaemia of the limb extremities causing peripheral gangrene has been reported in children (Lloyd, Kemball, and Fraser, 1967) . These cases were thought to result from primary arterial disease, and Lowenthal (1967) glutinins and cryoglobulins, and the term 'Raynaud's phenomenon' should be restricted to these cases. In this patient the striking symmetry of distribution of the ischaemia (Fig.) , the failure to demonstrate a precipitating cause, and the functional nature of the circulatory impairment confirm the diagnosis of Raynaud's disease. The total hand flow found here is also reduced compared with adult values (Wade, 1965) , though no strict control flows for children are available. Reduction in hand flow has been demonstrated in adults (Peacock, 1960) .
Some authors (Mendlowitz and Naftchi, 1959) still feel that there is sympathetic overactivity in these cases, and it is of interest that the mother volunteered the information that the child had shown increased sweating.
Acquired rubella was possibly incriminated as the cause of the Raynaud's disease in this case. The raised antibody titre supported the clinical diagnosis of a recent infection, and rubella infection may be associated with increased capillary fragility (Lokietz and Reynolds, 1965) . Previously reported cases of rubella have not shown evidence of arterial spasm. Serre and Simon (1962) thought that griseofulvin exerted its effect through the sympathetic system in cases of shoulder-hand syndrome. Forck and Fegeler (1962) investigated adults with onychomycosis in whom there was associated digital arterial spasm; pulse height tracings showed relief of the spasm after 72 hours of treatment with griseofulvin 750-1500 mg. per day. Rubin (1963) has shown that griseofulvin increases coronary blood flow by a direct effect on vascular smooth muscle. This effect was not altered by blocking of autonomic ganglia (hexamethonium chloride), adrenergic receptors (phentolamine hydrochloride), cholinergic receptors (atropine), and histamine receptors (chlorpheniramine maleate). Sforza and Mossa (1964) , following a study of 12 patients with chronic disorders of peripheral arteries, concluded that griseofulvin was a good vasodilator, probably acting directly on the blood vessels.
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